1. 2325 Targeting isoform-specific PI3 kinase signaling for treatment of cutaneous T cell lymphoma. (21st November 2018) Authors: Raychaudhuri, Suravi; Wu, Chi-Heng; Ai, Weiyun Journal: Journal of clinical and translational science Issue: Volume 2(2018)Supplement 1 Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Current and emerging treatment options in primary mediastinal B-cell lymphoma. (October 2021) Authors: Fakhri, Bita; Ai, Weiyun Journal: Therapeutic advances in hematology Issue: Volume 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cutaneous T-cell lymphoma patient-derived xenografts retain molecular characteristics across passages. (October 2021) Authors: Snowden, Caroline; Wu, Chi-Heng; Ringbloom, Kimberly; Lee, Katie; Ai, Weiyun; Choi, Jaehyuk Journal: European journal of cancer Issue: Volume 156(2021)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of pulmonary toxicities in lymphoma patients receiving brentuximab vedotin. Issue 12 (15th October 2022) Authors: Guan, Tiffany; Lo, Mimi; Young, Rebecca; Ai, Weiyun; Boulbol, Fouad; Mouanoutoua, Hanson; Chu, Raymond; Andreadis, Charalambos; Kaplan, Lawrence; Abdulhaq, Haifaa; Fakhri, Bita Journal: Leukemia & lymphoma Issue: Volume 63:Issue 12(2022) Page Start: 3008 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial. Issue 6 (June 2021) Authors: Caimi, Paolo F; Ai, Weiyun; Alderuccio, Juan Pablo; Ardeshna, Kirit M; Hamadani, Mehdi; Hess, Brian; Kahl, Brad S; Radford, John; Solh, Melhem; Stathis, Anastasios; Zinzani, Pier Luigi; Havenith, Karin; Feingold, Jay; He, Shui; Qin, Yajuan; Ungar, David; Zhang, Xiaoyan; Carlo-Stella, Carmelo Journal: Lancet oncology Issue: Volume 22:Issue 6(2021) Page Start: 790 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma. Issue 4 (21st March 2022) Authors: Halwani, Ahmad S.; Panizo, Carlos; Isufi, Iris; Herrera, Alex F.; Okada, Craig Y.; Cull, Elizabeth H.; Kis, Bela; Chaves, Jorge M.; Bartlett, Nancy L.; Ai, Weiyun; de la Cruz-Merino, Luis; Bryan, Locke J.; Houot, Roch; Linton, Kim; Briones, Javier; Chau, Ian; von Keudell, Gottfried R.; Lu, Hailin... Journal: Leukemia & lymphoma Issue: Volume 63:Issue 4(2022) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗